(Q83846416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

metastatic breast cancer

1 reference

6

R E Champlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

5

R B Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

J A de Souza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M L Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

G Rondon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Y C Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

N T Ueno

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

18 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

81-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19448681%20AND%20SRC:MED&resulttype=core&format=json

Can we cure limited metastatic breast cancer?

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Current role of allogeneic stem cell transplantation in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Profound graft-versus-tumor response in metastatic breast cancer with nonmyeloablative allografting

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.101

7 January 2021